Athyrium Capital Announces Sale of Shares of HLS Therapeutics
Article content NEW YORK, June 30, 2023 (GLOBE NEWSWIRE) -- Athyrium Capital Management, LP announces that the funds it manages have sold a total of 1,300,000 common shares of HLS Therapeutics ("institution’) on the facilities of the…
